Carlos de Sousa, CEO of Ultimovacs, presents the company at BioStock Life Science Fall Summit 2022.
BioStock Life Science Summit 2022 is presented in collaboration with Nasdaq Nordic, Back Bay Life Science Advisors, Accountor and Haeger & Carlsson.
Enter the prentation HERE
0:00 Introduction to Ultimovacs
2:55 Financial status
3:54 Pipeline
4:07 UV1clinical programme
5:26 Data so far
6:45 Overall survival data
7:10 UV1 pipeline
7:59 Market potential
8:30 Expected news flow and milestones
9:50 Summary
10:30 Q&A